Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vivo transgenic mutation assays.

Véronique Thybaud1, Stephen Dean, Takehiko Nohmi

  • 1Aventis Pharma, Drug Safety Evaluation, Vitry-sur-Seine, France. veronique.thybaud@aventis.com

Mutation Research
|October 11, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutagenicity of EAT-positive NDSRIs in HepaRG spheroids.

NAM journal·2026
Same author

Adjusting the Preincubation Conditions to Enhance the Ames Test for Detecting the Mutagenicity of N-Nitrosamines.

Environmental and molecular mutagenesis·2026
Same author

Comparative genotoxicity assessment of ortho-phthalaldehyde using human in vitro organotypic airway epithelial cultures and standard in vitro genotoxicity assays.

Archives of toxicology·2026
Same author

Mutagenicity of N-nitroso-fluoxetine and N-nitroso-varenicline in human HepaRG cell models.

Mutagenesis·2026
Same author

Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop.

Mutagenesis·2026
Same author

Quantitative evaluation of genotoxicity data for risk assessment and regulatory decision-making: Time for a paradigm shift.

Environment international·2026

This study refines protocols for transgenic rodent gene mutation assays, ensuring reliable detection of DNA mutations for regulatory use. Standardized methods improve genetic toxicology testing efficiency and accuracy.

Area of Science:

  • Genetic Toxicology
  • Molecular Biology
  • Biomedical Research

Background:

  • Transgenic rodent models offer rapid and reliable gene mutation detection in DNA from various tissues.
  • Previous International Workshop on Genotoxicity Testing (IWGT) meetings established foundational principles for these assays.
  • Consensus on specific methodological details for regulatory applications remained to be finalized.

Purpose of the Study:

  • To summarize previously agreed-upon issues and discuss unresolved topics for transgenic rodent gene mutation assays.
  • To establish standardized protocols for regulatory applications, ensuring assay availability, transferability, and use of neutral genes.
  • To provide updated recommendations on experimental design, data reporting, and statistical analysis.

Main Methods:

Related Experiment Videos

  • Summarized previously agreed-upon issues and discussed unresolved topics from prior IWGT meetings.
  • Proposed standardized protocols for phage-based assays, including animal numbers, sample sizes (plaque or colony forming units), and control groups.
  • Recommended a general 28-day daily treatment protocol with tissue sampling three days post-treatment, allowing for justified modifications.

Main Results:

  • Agreed upon a general protocol for daily treatment over 28 days, with tissues sampled post-treatment.
  • Recommended specific statistical approaches, considering the animal as the experimental unit and utilizing nonparametric tests.
  • Defined criteria for positive and negative results based on statistically significant dose-response or changes compared to controls.

Conclusions:

  • Established consensus on key aspects of transgenic rodent gene mutation assays for regulatory use.
  • Recommended standardized protocols for experimental design, data analysis, and interpretation to enhance reliability and comparability.
  • Highlighted the potential utility of sequencing data for specific mechanistic investigations, while not being a routine requirement.